The CRISPR / Cas technology applied to mouse genetic engineering could quickly advance scientific understanding of disease mechanisms by allowing researchers to ask complex questions and find answers much faster than with traditional
gene targeting approaches.
Not exact matches
Well, one startup is seeking to take a very different
approach: Exonics Therapeutics, which has secured $ 5 million in seed funding from CureDuchenne Ventures to see if the revolutionary new CRISPR - Cas - 9
gene - editing technology can be used to
target the root genetic deficiency at the heart of the disease.
This study took a different
approach —
targeting a drug to a protein that controls how
genes are turned on and off, early in the viral replication process.
«What we decided to do was take a completely unbiased
approach where instead of
targeting individual
genes of interest, we would express randomized guides inside of the cell,» Lu says.
The findings by a team of Massachusetts General Hospital (MGH) investigators, which will be published in the April 24 issue of Cell and are receiving advance online release, support the importance of epigenetics — processes controlling whether or not
genes are expressed — in cancer pathology and identify molecular circuits that may be
targeted by new therapeutic
approaches.
Most therapeutic
approaches ignore the dynamic molecular network of
genes,
targeting instead only very few selected disease - related
genes.
However, they determined the blood levels of SMN are not altered when SMN levels are altered in motor neurons using a
gene therapy
approach delivered directly into the cerebrospinal fluid to
target the central nervous system.
Earlier MD Anderson investigations demonstrated exosomes as a factor in detecting pancreatic cancer, but these latest findings reveal genetically altered exosomes as a potentially novel
approach for direct and specific
targeting of mutated KRAS, the cancer
gene commonly linked to pancreatic cancer.
The proposed strategy reflects a continuing move toward combination therapies, particularly when it comes to epigenetic
approaches, which
target the mechanisms that control whether
genes are switched «on» or «off.»
«The trial is important for
gene research and may be a proof of principle that
targeting the most common mutation in cystic fibrosis is an effective
approach for treatment of most patients,» Gentzsch said.
Despite this new direction for identifying
targets for pharmaceutical interventions against RP, the researchers underscore that
gene therapy still has great potential and possible benefits, and they are actively pursuing efforts with this
approach for several forms of RP.
«Depending on the research questions, it may also be important to define the appropriate strategy to use, either whole - genome sequencing or just
targeting some genomic regions with a
gene baiting
approach,» says Besnard.
Rather than
target a tumor - suppressor
gene directly, Ideker and team took the
approach of identifying genetic interactions between a tumor suppressor
gene and another
gene, such that simultaneous disruption of both
genes selectively kills cancer cells.
With the data provided by the FLI researchers, scientists around the world may now set
targeted mutations to investigate the relevance of single
genes for aging, in order to better understand regulating mechanisms and, eventually, develop new
approaches for therapy or prevention of aging - related diseases.
This understanding of cancer's evolution has key implications for treatment, he noted, «In addition to pointing out that we will need to
target driver
genes that are mutated early in cancer, this evolutionary
approach provides a method that accurately characterizes which
genes are being mutated early and late.
His team's
approach is based on
gene therapy, where a «tame» virus is harnessed to transfer a
gene into
target cells in the recipient.
One general benefit of the RNAi
approach, Zhang says, is that researchers can selectively
target specific insect pests by
targeting species - specific
gene sequences; this avoids the blanket destruction of other insect species seen with many insecticides, he explains.
As the central nervous system is also a
target of AAV vectors, Hélène Puccio and Patrick Aubourg's teams are investigating whether a similar
approach using
gene therapy could be as effective for the spinal cord and cerebellum as it is for the heart.
Experimental
approaches such as
gene therapy are also being investigated, but Dr. Rudnicki's research suggests that these
approaches will have to be modified so that they
target muscle stem cells as well as muscle fibres.
Her team integrates both computational and experimental
approaches to explore how perturbations to these
gene networks can alter morphology, both within a species and across the grasses, with the ultimate goal of defining
targets for improving grain yield in cereals.
While circulating tumor DNA tests
targeting a smaller set of cancer
genes are already available for use in routine practice to guide care, by covering a much larger number of cancer
genes, this high - intensity sequencing
approach may enable development of future tests for early detection of cancer.
But so far, silencing
genes using RNAi has not worked well in mammalian cells; although the
approach has been successful in mouse embryos, double - stranded RNA shuts down synthesis of all proteins, not just the
target gene, in other types of mammalian cells.
This common genetic heritage is a potential achilles heel of the metastases, however, many of these shared mutations are in tumor suppressor
genes and our
approach to therapeutically
targeting these needs to be prioritised.
In an effort to combine the respective advantages of the AAV and CRISPR - based
approaches, several groups have recently worked to enhance the efficiency of AAV - based
gene editing via the introduction of a double strand break by using a
targeted nuclease.
Utilizing genetic
approaches such as «fine mapping» and «genome editing,» the researchers narrowed the region of the chromosome and
targeted each
gene to responsible for affecting the behavioral response to the drug.
First, unlike CRISPR, the AAV - based
approach is only able to
target a single allele of a single
gene at once.
«This study suggests that
targeting p27, GATA3 and POU4F3 may enhance the outcome of
gene therapy and other
approaches that aim to restart ATOH1 expression,» Zuo said.
However, like most
gene transfer
approaches a major concern with ZFN technology is the potential for oncogenesis due to off -
target effects.
This study is good example of a precision medicine themed
approach to showing how a mechanistic understanding of the differential
gene expression can yield biomarkers that can be used for early detection of disease, as well as potential therapeutic
targets.
His work centers on developing general, rational
approaches to design precision medicines from genome sequences by
targeting the RNA product of
genes.
Through its population - based
approach and three main business units providing disease -
gene and drug
target identification, database services and informatics tools, deCODE is turning raw genomics data into products and services for the healthcare industry.
This service will complement the shRNA core facility as many
gene functions are masked or skewed due to the partiality, off -
target, and transient nature of the knockdown
approach.
This
approach will allow you to insert luminescent or fluorescent reporter
genes in specific
target sites.
Also, a different
targeting approach leading to the use of the native 3 ′ UTR and removal of the neo
gene resulted in normalisation of XpdXPCS mRNA levels and viable homozygous XpdXPCS / XPCS (XPDG602D / G602D) animals [23].
More specifically, he has developed therapeutic
approaches that
target gene - control mechanisms in the stressed and failing heart, a process that has striking similarities to uncontrolled growth in cancers.
This
approach allows to obtain models in shorter timelines and with reduced costs compared to
gene targeting by homologous recombination in ES cells.
Drug discovery for genetic diseases: Screening technologies are applied to identify chemical compounds able to inhibit REST function, a major
target gene in Huntington's disease, and will serve as a paradigm for high - throughput screening
approaches applied to neurological disorders.
Most therapeutic
approaches ignore the dynamic molecular network of
genes,
targeting instead...
In an interdisciplinary
approach, the team will first systematically identify
genes that are required for this differentiation process - information which will then be used to investigate their molecular mode of action, their
targets, and if and how they interact with each other.
We are using live imaging, transgenic reporters of osteoblast
gene expression and
targeted RNAseq
approaches to identify the molecular regulators of progressive osteoblast differentiation during expansion of the skull.
Ensuring appropriate
target gene selection and maintaining a diversified pre-clinical engine are key aspects of our strategic
approach.
We have demonstrated that our liposomes can mediate in vivo
target mRNA delivery as well as
gene disruption using an entirely RNA - based
approach.
Following a Forward Genetics
approach, Fleming researchers identified a novel neurological mouse model caused by a functional mutation in the Slc25a46
gene, a new pathogenic
target in a wide spectrum of human neurological diseases, including optic atrophy, Charcot - Marie - Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.
Once these
target genes are identified, he then uses a combination of
gene therapy - and medication - based
approaches to block the function of these
genes and potentially halt the disease.
The
approach to
target validation utilizes RNAi, CRISPR, and ORF expression platforms to genetically perturb candidate
target gene expression in relevant cancer cell lines, and then profile the resulting phenotypic changes with regard to their effect on various biochemical pathways.
«Our breakthrough findings in psoriasis underscore the unique power of our population
approach for tackling the genetics of just about any common condition, and we hope to push this program forward to identify the
gene involved as well as
targets for the development of new therapies,» said Dr. Kari Stefansson, CEO of deCODE genetics.
Given the tailored inhibition of selected
genes and the added precision brought by
targeted delivery systems, RNAi - based therapies are thought to carry lower risk of failure than traditional
approaches as the biological effects are more predictable.
The
gene -
targeting approach developed by Suzuki and his colleagues relies on the use of so - called helper - dependent adenoviral vector to deliver large mutation - free DNA molecules into cells.
This
approach allows to obtain mouse models in shorter timelines and with reduced costs compared to
gene targeting by homologous recombination in ES cells.
Their contributions to the yeast community include physical mapping methods, synthetic lethality screen
approaches for identifying cross-species candidate
genes as potential cancer drug
targets, and a widely used set of vectors and yeast host strains that have been instrumental in work that has led to countless discoveries in recent decades.